COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
University of Cambridge > Talks.cam > CamBioScience's Two-day Intensive courses in Emerging Life Science Technologies > EMERGING EPIGENETICS: DETECTING & MODIFYING EPIGENETICS MARKS
EMERGING EPIGENETICS: DETECTING & MODIFYING EPIGENETICS MARKSAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Dr. Chibeza C. Agley. Two-day intensive course 12th & 13th March 2018 The sequence of DNA within every cell of a multicellular organism is essentially equivalent and invariable. However, multicellular organisms are made of hundreds of cell types, each with unique cellular programs, morphologies and functions. This incredible variety results from the regulation of the epigenome, which consists of the chromatin and its chemical modifications. The epigenome is dynamic and acts as an interface between environmental signals and the genetic code. Alterations in epigenetic programming affect gene function in the absence of an underlying change in the DNA sequence via a number of mechanisms which include: Histone post-translational modifications: methylation, phosphorylation, acetylation, sumoylation, and ubiquitination. DNA methylation and hydroxymethylation. Small noncoding RNAs, termed microRNAs or ncRNAs which can silence chromatin, degrade mRNA, or block translation Technological advances, such as chromatin immunoprecipitation followed by next-generation sequencing (ChIP–Seq), and variations on this, have enabled the analysis of the epigenome at base-pair resolution and allowed ‘epigenomic profiling’ in both normal and abnormal cells and tissues. Epigenomic profiling has already proved invaluable by helping to better define critical DNA control elements, such as gene enhancers and promoters. Numerous human diseases are characterised by a departure from the normal pattern of gene expression and errors in epigenetic processes underpin many of these. However, the reversible nature of most of the known epigenetic modifications of chromatin offer promising therapeutic opportunities for the controlled regulation of disease-related genes via the manipulation of epigenetic mechanisms. With the development of a new suite tools including CRISPR mediated ‘epigenome-editing’, epigenetics will continue to be one of the most innovative research areas in the life sciences and medicine. On this two-day intensive course you will:
Visit our VIDEO ROOM for impressions of our past courses. This talk is part of the CamBioScience's Two-day Intensive courses in Emerging Life Science Technologies series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsCambridge Journal of Regions, Economy and Society Faculty of Economics Philiminality CambridgeOther talksPropagation of Very Low Frequency Emissions from Lightning Gaze and Locomotion in Natural Terrains Art speak Developing and Selecting Tribological Coatings Mesembs - Actual and Digital UK 7T travelling-head study: pilot results |